Iron Deficiency Anemia Therapy Market Size, Share, Growth 2023
The Fortune Business Insights adds Global "Iron Deficiency Anemia Therapy Market" 2023-2029 report that offers an total content of the assiduity with brief analysis, data maps, numbers, statistics that help take business opinions, company biographies and further.
The Complete report specifies the historical, present,
and projected size of the market from the standpoint of both value and volume.
SWOT and Value Chain Analysis are utilized to gauge the market. The market is
very fragmented by type and application, with sales market share and rate of
growth by type, application.
Also report compromises in-depth analysis covering key
regional trends, market dynamics, and provides country-level market size of the
worldwide Iron Deficiency Anemia Therapy Market.
Get a Free Sample Research PDF :
https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/103498
About Iron Deficiency Anemia Therapy Market
Growth and Size
In January 2020, the U.S. FDA announced the approval
of ferric derisomaltose injection of PHARMACOSMOS A/S for the treatment of iron
deficiency anemia in adults who had an intolerance or unsatisfactory response
to oral iron or who have nonhemodialysis-dependent chronic kidney disease.In
December 2016, Nippon Shinyaku Enters into a License Agreement with
PHARMACOSMOS A/S on an intravenous iron therapy, Monofer (Iron Isomaltoside
1000)
The global Iron Deficiency Anemia Therapy Market
was valued at USD million in 2022 and is anticipated to reach USD million by
2029, witnessing a CAGR of during the forecast period 2023-2029. The influence
of COVID-19 and the Netherlands-Ukraine War were considered while estimating
market sizes.
North American Iron Deficiency Anemia Therapy Market is estimated to
increase from USD million in 2023 to reach USD million by 2029, at a CAGR of
during the forecast period of 2023 through 2029.
Asia-Pacific Iron Deficiency Anemia Therapy Market is estimated to
increase from USD million in 2023 to reach USD million by 2029, at a CAGR of
during the forecast period of 2023 through 2029.
Iron Deficiency Anemia Therapy Market Research is
spread across 100+ pages
and provides exclusive data, information, vital statistics, trends and
competitive landscape details in this niche sector.
Major Players in Iron Deficiency Anemia Therapy
Market 2023 are:
Some of the major companies that are present in the
iron deficiency anemia therapy market are Sanofi S.A., Allergan (AbbVie),
PHARMACOSMOS A/S, Pieris, AMAG Pharmaceuticals, Bayer AG, Apotex Inc.,
Acceleron Pharma, Inc., and other prominent players.
For More Information :
https://www.fortunebusinessinsights.com/iron-deficiency-anemia-therapy-market-103498
About Us:
Fortune Business Insights™ delivers accurate
data and innovative corporate analysis, helping organizations of all sizes make
appropriate decisions. We tailor novel solutions for our clients, assisting
them to address various challenges distinct to their businesses. Our aim is to
empower them with holistic market intelligence, providing a granular overview
of the market they are operating in.
Contact Us:
Fortune Business Insights™ Pvt. Ltd
U.S.: +1 424 253 0390
U.K.: +44 2071 939123
APAC: +91 744 740 1245
Comments
Post a Comment